Stem cell–fortified eye drops to improve tear stability and dry eye symptoms in people with cataract or dry eye

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase 4 interventional protocol tests topical eye drops fortified with stem cell‑derived factors aimed at improving tear film stability, tear volume, and patient‑reported dry eye symptoms. Adults aged 18–80 with clinically diagnosed dry eye (for example by OSDI and Schirmer testing) receive the investigational drops and are followed for changes in objective tear metrics and symptom scores. Major exclusions include prior ocular surgery or trauma, other active ocular diseases (such as glaucoma or keratitis), and systemic conditions that could confound results. The trial is sponsored by Ace Cells Lab Limited in collaboration with the University of Nottingham and is listed at the British Center for Regenerative Medicine in Giza.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults aged 18-80 years.
* Diagnosed with dry eye disease (based on clinical criteria such as OSDI scores and Schirmer test results).

Exclusion Criteria:

* Exclusion Criteria:

  * History of ocular surgery or trauma.
  * Other ocular diseases (e.g., glaucoma, keratitis).
  * Systemic conditions that may interfere with study outcomes (e.g., autoimmune diseases).

Where it's running

• British center for regenerative medicine
  Giza, Egypt Recruiting

Study contacts

• Principal investigator: Mohammed Yasser Sayyed Saif, Prof of ophthalmology — Beni-Suef University
• Study coordinator: Dr. Alaa Abdelkarim DAF Fouad, MD, MBBCHConsultant stem cells
• Email: dralaa@ace-cells.co.uk
• Phone: +447473922553

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Effect of Dry Eye Treatment on Corneal Astigmatism Measurements

  This study tests whether short-term treatment for dry eye changes how consistently three devices measure corneal astigmatism in people preparing for cataract surgery.

  Recruiting Eye & ENT Hospital of Fudan University · Shanghai, Shanghai Municipality · NCT07657858

• Rotational Stability of the Acunex Vario Toric

  This study tests whether the Acunex Vario toric extended-depth-of-focus intraocular lens stays stable in rotation and effectively reduces astigmatism for people undergoing cataract surgery.

  Recruiting Vienna Institute for Research in Ocular Surgery · Vienna · NCT07925840

• Anterior segment anatomy assessment with swept-source OCT in eye surgery patients

  This study tests whether swept-source OCT can detail front-eye anatomy in patients undergoing anterior segment eye surgery.

  Recruiting Nanfang Hospital, Southern Medical University · Guangzhou, Guangdong · NCT07903454

• MiLOOP-assisted cataract surgery for dense cataracts

  In people with dense cataracts, this study tests whether using the miLOOP device during cataract surgery can protect corneal cells and reduce ultrasound energy, compared with standard surgery.

  Recruiting Universiti Kebangsaan Malaysia Medical Centre · Cheras, Kuala Lumpur · NCT07898007

• Lacrifill to Help Prevent Post-Curgery Dry Eye After Cataract Surgery

  This study tests Lacrifill to see if it helps prevent dry eye symptoms after unilateral cataract surgery.

  Recruiting at 2 sites Phase 4 Eye Research Associates, LLC · Pittsburg, Kansas and 1 other locations · NCT07796178

• Tear-Fluid Stability Testing with iTrace, BOSA, OPD-Scan III, and IDRA for Dry Eye

  A Phase 4 study tests whether four eye devices can detect tear film stability in adults with normal tear film.

  Recruiting Phase 4 Vance Thompson Vision · Sioux Falls, South Dakota · NCT07790211

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.